Showing results (741-750 of 14,088) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|February 16, 2016
Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapyAnupama Chundury, Anthony Apicelli, Todd DeWees, et al.Gynecologic Oncology|March 17, 2016
Laparoendoscopic single-site surgery in gynecologic oncology: An updateDavid M BorutaGynecologic Oncology|April 14, 2016
Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology groupKenichi Harano, Akihiro Hirakawa, Mayu Yunokawa, et al.Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.Gynecologic Oncology|October 18, 2015
The performance of Dynamic Spectral Imaging colposcopy depends on indication for referralsJ A Louwers, A Zaal, M Kocken, et al.Gynecologic Oncology|August 31, 2015
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC)Heike Seifert, Alexandros Georgiou, Helen Alexander, et al.Gynecologic Oncology|December 3, 2014
Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysisGiorgio Bogani, William A Cliby, Giovanni D AlettiGynecologic Oncology|December 3, 2014
A systematic review of the supportive care needs of women living with and beyond cervical cancerRoma Maguire, Grigorios Kotronoulas, Mhairi Simpson, et al.Gynecologic Oncology|December 3, 2014
A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancerVictoria Plamadeala, Joseph L Kelley, John K Chan, et al.Gynecologic Oncology|December 3, 2014
Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicityYeong-In Yang, Ji-Hye Ahn, Youn Seok Choi, et al.Pageof 1,409